Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Luther Medical/MedChem

This article was originally published in The Gray Sheet

Executive Summary

Catheter systems manufacturer Luther Medical receives acquisition offer from MedChem Products. According to Luther, MedChem is opening negotiations "with a valuation range of $3.50- 4 per share, payable in cash and/or MedChem common stock," making the deal worth $10-11.5 mil. On Sept. 15, the day of the MedChem offer, Luther stock closed at $2.875 per share. Commenting on the offer, Luther President and CEO David Rollo says that the company's board "will meet soon to consider the MedChem proposal seriously"



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts